Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zimmer

Showing results (441-450 of 457) with videos related to

Pageof 46
Sort By:
JAMA|July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical TrialJohn R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
The Journal of Prevention of Alzheimer'S Disease|December 2, 2025
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extensionJennifer A Zimmer, John R Sims, Cynthia D Evans, et al.
JAMA Neurology|March 10, 2025
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical TrialsJennifer A Zimmer, Paul Ardayfio, Hong Wang, et al.
Preventive Veterinary Medicine|March 8, 2011
Towards a standardised surveillance for Trichinella in the European UnionL Alban, E Pozio, J Boes, et al.
JAMA Neurology|November 26, 2019
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical TrialsAlette M Wessels, Pierre N Tariot, Jennifer A Zimmer, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2022
Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical SpeciesBrian A Willis, Stephen L Lowe, Scott A Monk, et al.
Nature Sustainability|October 10, 2022
Assessing placement bias of the global river gauge networkCorey A Krabbenhoft, George H Allen, Peirong Lin, et al.
Molecular Psychiatry|April 5, 2017
A paternal methyl donor-rich diet altered cognitive and neural functions in offspring miceD P Ryan, K S Henzel, B L Pearson, et al.
Wires. Water|August 18, 2020
Zero or not? Causes and consequences of zero-flow stream gage readingsMargaret A Zimmer, Kendra E Kaiser, Joanna R Blaszczak, et al.
Nature Genetics|August 10, 2000
Genome-wide, large-scale production of mutant mice by ENU mutagenesisM H Hrabé de Angelis, H Flaswinkel, H Fuchs, et al.
Pageof 46

Showing results (441-450 of 457) with videos related to

Sort By:
Pageof 46
JAMA|July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical TrialJohn R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
The Journal of Prevention of Alzheimer'S Disease|December 2, 2025
Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extensionJennifer A Zimmer, John R Sims, Cynthia D Evans, et al.
JAMA Neurology|March 10, 2025
Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical TrialsJennifer A Zimmer, Paul Ardayfio, Hong Wang, et al.
Preventive Veterinary Medicine|March 8, 2011
Towards a standardised surveillance for Trichinella in the European UnionL Alban, E Pozio, J Boes, et al.
JAMA Neurology|November 26, 2019
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical TrialsAlette M Wessels, Pierre N Tariot, Jennifer A Zimmer, et al.
Journal of Alzheimer'S Disease Reports|March 4, 2022
Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical SpeciesBrian A Willis, Stephen L Lowe, Scott A Monk, et al.
Nature Sustainability|October 10, 2022
Assessing placement bias of the global river gauge networkCorey A Krabbenhoft, George H Allen, Peirong Lin, et al.
Molecular Psychiatry|April 5, 2017
A paternal methyl donor-rich diet altered cognitive and neural functions in offspring miceD P Ryan, K S Henzel, B L Pearson, et al.
Wires. Water|August 18, 2020
Zero or not? Causes and consequences of zero-flow stream gage readingsMargaret A Zimmer, Kendra E Kaiser, Joanna R Blaszczak, et al.
Nature Genetics|August 10, 2000
Genome-wide, large-scale production of mutant mice by ENU mutagenesisM H Hrabé de Angelis, H Flaswinkel, H Fuchs, et al.
Pageof 46